
Commissioner Makary joins FDA’s Chief AI Officer Jeremy Walsh and two industry leaders to discuss the advancement of real-time clinical trials, which can accelerate drug development and help the agency make decisions...


science
Hosted by U.S. Food and Drug Administration · science · EN
Commissioner Makary and other members of FDA leadership, as well as guests, engage in timely and frank discussions to bring you an inside look at the current happenings at the FDA.
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Verified email
Booking probability
20%
Guest openness
Selective
Sign up to generate a grounded pitch for FDA Direct.
Signup to Generate a PitchCommissioner Makary and other members of FDA leadership, as well as guests, engage in timely and frank discussions to bring you an inside look at the current happenings at the FDA.
FDA Direct is hosted by U.S. Food and Drug Administration. The show has published 25 episodes to date.
Recent episodes include "FDA Direct: The Power of Real-Time Clinical Trials" (29 April 2026, 47 minutes), "FDA Direct: The Power of Real-Time Clinical Trials" (29 April 2026, 47 minutes), and "FDA Direct - Special Edition of FDA Direct" (1 April 2026, 51 minutes).
FDA Direct publishes roughly monthly, with episodes averaging 37 minutes across 25 episodes.
Booking probability for FDA Direct is 20%, and the host is rated Selective on guests. FDA Direct requires a Pod Score of 80 or higher. FDA Direct's contact route on record: verified email.
The strongest fits for FDA Direct are Government & Politics and Health & Wellness Services. FDA Direct has a science audience.
U.S. Food and Drug Administration hosts FDA Direct, a science podcast with 25 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

Commissioner Makary joins FDA’s Chief AI Officer Jeremy Walsh and two industry leaders to discuss the advancement of real-time clinical trials, which can accelerate drug development and help the agency make decisions...

Commissioner Makary joins FDA’s Chief AI Officer Jeremy Walsh and two industry leaders to discuss the advancement of real-time clinical trials, which can accelerate drug development and help the agency make decisions...

Recapping a year's worth of progress, taking a moment to recognize our amazing staff, and discussing what's next for the FDA.

Recapping a year's worth of progress, taking a moment to recognize our amazing staff, and discussing what's next for the FDA.

Join FDA Commissioner Marty Makary and Director of the Office of the Secretariat Elisabeth Armstrong as they talk with FDA Chief of Staff Jim Traficant about the impact rare disease has had on his life, and how his...

Join FDA Commissioner Marty Makary and Director of the Office of the Secretariat Elisabeth Armstrong as they talk with FDA Chief of Staff Jim Traficant about the impact rare disease has had on his life, and how his...

Listen as we discuss new CDER leadership, how CDER & CBER will collaborate to bring more consistency to reviews, and the action we took on HRT this week.

Listen as we discuss new CDER leadership, how CDER & CBER will collaborate to bring more consistency to reviews, and the action we took on HRT this week.

Practicing doctors share their perspectives on the use of HRT for menopausal women and the FDA's action to remove boxed warnings.

Practicing doctors share their perspectives on the use of HRT for menopausal women and the FDA's action to remove boxed warnings.

Learn more about why the FDA is initiating label changes for hormone replacement therapy products for menopausal women.

Listen as FDA Commissioner Dr. Makary and Deputy Chief Medical Officer Dr. Mallika Mundkur discuss the next batch of awardees under the Commissioner’s National Priority Voucher program.

Biologic drugs are incredible, but they’re expensive – and they account for 51% of all drug spending. How can we bring cheaper alternatives to market?

It’s amusing when reporters and writers do not have access to FDA information on manufacturing and sterility violations — yet make calls from the peanut gallery.

FDA Direct: These 9 Drugs Were Awarded National Priority Vouchers

Get to know more about CVM Acting Director, Dr. Timothy Schell as he talks about screwworm, his passion for animal health especially pigs.

FDA Direct: Citrus Regs, Natural Dye Pledges, and Hidden Opioids

FDA Direct
Today’s FDA Direct focuses on 7-OH, a dangerous opioid found in candies, gummies, drink mixes, and even ice cream cones sold at vape shops across the country. The conversation also touches upon ultra processed foods...

Listen as FDA Commissioner, Dr. Marty Makary, speaks with Dr. George Tidmarsh, the new Director of FDA’s Center for Drug Evaluation and Research about the future of drug regulation at the FDA.

FDA Direct, Ep. 12 – From Menopause to Food Safety: FDA's Latest Regulatory Priorities
Recent guests on FDA Direct. Study who booked and why before you pitch.
FDA
FDA
PitchCentric classifies FDA Direct under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ